Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (253)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Molecule	Drug Class / Mechanism	Oncology Type
Vemurafenib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Vemurafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Vismodegib	Hedgehog Pathway Inhibitor	Solid Tumour / Hematologic (AML)
Molecule Vismodegib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour / Hematologic (AML) Drug Class / Mechanism Hedgehog Pathway Inhibitor
Vistusertib	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Vistusertib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Vodobatinib	BCR-ABL Tyrosine Kinase Inhibitor	Hematologic (Leukemia)
Molecule Vodobatinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Vorasidenib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Vorasidenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Vorinostat	HDAC Inhibitor	Hematologic (Lymphoma)
Molecule Vorinostat Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Vorolanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Vorolanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Voruciclib	CDK Inhibitor	Solid Tumour
Molecule Voruciclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Zandelisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Zandelisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Zidesamtinib	ROS1-Selective Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Zidesamtinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ROS1-Selective Tyrosine Kinase Inhibitor
Ziftomenib	EZH2 / Menin Inhibitor	Hematologic
Molecule Ziftomenib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Zorifertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Zorifertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor

Vemurafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Vismodegib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour / Hematologic (AML) Drug Class / Mechanism Hedgehog Pathway Inhibitor
Vistusertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Vodobatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Vorasidenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Vorinostat Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Vorolanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Voruciclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Zandelisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Zidesamtinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ROS1-Selective Tyrosine Kinase Inhibitor
Ziftomenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Zorifertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor

‹ 1 … 19 20 21 22 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (253)

Vemurafenib

Vismodegib

Vistusertib

Vodobatinib

Vorasidenib

Vorinostat

Vorolanib

Voruciclib

Zandelisib

Zidesamtinib

Ziftomenib

Zorifertinib

Vemurafenib

Vismodegib

Vistusertib

Vodobatinib

Vorasidenib

Vorinostat

Vorolanib

Voruciclib

Zandelisib

Zidesamtinib

Ziftomenib

Zorifertinib